Aristotelis Nastos
Director/Board Member chez AYOXXA Biosystems GmbH
Profil
Aristotelis Nastos is currently the Director at CEVEC Pharmaceuticals GmbH, Executive Managing Director at NRW.Bank (Private Equity), Director at DIREVO Industrial Biotechnology GmbH, Director at Cryotherapeutics SA, Director at Fasciotens GmbH, Director at Abalos Therapeutics GmbH, Director at Resolve BioSciences GmbH, Director at Cryotherapeutics GmbH, and Member-Supervisory Board at AYOXXA Biosystems GmbH.
He previously worked as the Chairman-Supervisory Board at Scienion AG, Director at Protagen AG, Independent Director at BICO Group AB, Investment Manager at NRW.Bank (Private Equity), Principal at Peppermint Holding GmbH, and Partner at Creathor Venture Management GmbH.
Dr. Nastos holds a graduate degree from Ruhr-Universität Bochum and a doctorate degree from the University of Duisburg-Essen.
Postes actifs de Aristotelis Nastos
| Sociétés | Poste | Début |
|---|---|---|
DIREVO Industrial Biotechnology GmbH
 DIREVO Industrial Biotechnology GmbH Miscellaneous Commercial ServicesCommercial Services DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany. | Director/Board Member | - |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Director/Board Member | 01/06/2011 |
CEVEC Pharmaceuticals GmbH
 CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Director/Board Member | 01/11/2009 |
NRW.Bank (Private Equity)
 NRW.Bank (Private Equity) Investment ManagersFinance NRW.Bank (Private Equity) (NRWB PE) is the private equity operating division of the NRW Bank which traces their origins to 2002 when Westdeutsche Landesbank Girozentrale was split up into two entities. From this basis and further to the 2004 Reorganization Act, the current foundations for NRW Bank were established. Headquartered in Dusseldorf, Germany, NRWB PE specializes in providing capital and business development support for SMEs in North Rhine-Westphalia. They manage a number of private equity funds. Through mezzanine capital as a co-investor alongside lead investors, they provide equity limited to minority stakes as a silent partner. | Private Equity Investor | 01/04/2017 |
Abalos Therapeutics GmbH
 Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany. | Director/Board Member | 01/09/2019 |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Director/Board Member | - |
Fasciotens GmbH
 Fasciotens GmbH Packaged SoftwareTechnology Services Fasciotens GmbH engages in the development of external medical device that provides solution for the open abdomen or abdominal compartment syndrome. It offers fasciotens abdomen. The company was founded by Gereon Lill and Frank Beyer in 2016 and is headquartered in Essen, Germany. | Director/Board Member | 01/02/2018 |
| Cryotherapeutics GmbH | Director/Board Member | 01/03/2012 |
Resolve BioSciences GmbH
 Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Director/Board Member | - |
| ░░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Aristotelis Nastos
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Aristotelis Nastos
| Ruhr-Universität Bochum | Graduate Degree |
| University of Duisburg-Essen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BICO GROUP AB | Health Technology |
| Entreprise privées | 14 |
|---|---|
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Health Technology |
NRW.Bank (Private Equity)
NRW.Bank (Private Equity) Investment ManagersFinance NRW.Bank (Private Equity) (NRWB PE) is the private equity operating division of the NRW Bank which traces their origins to 2002 when Westdeutsche Landesbank Girozentrale was split up into two entities. From this basis and further to the 2004 Reorganization Act, the current foundations for NRW Bank were established. Headquartered in Dusseldorf, Germany, NRWB PE specializes in providing capital and business development support for SMEs in North Rhine-Westphalia. They manage a number of private equity funds. Through mezzanine capital as a co-investor alongside lead investors, they provide equity limited to minority stakes as a silent partner. | Finance |
Scienion AG
 Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Health Technology |
Peppermint Holding GmbH
 Peppermint Holding GmbH TextilesProcess Industries Peppermint Holding GmbH operates as a holding company with interests in textile industries. Its company portfolios include Zwickauer Kammgarn, Ertex Jacquard, and Color Textil. The company was founded by Ingeborg Neumann in 1997 and is headquartered in Berlin, Germany. | Process Industries |
Creathor Venture Management GmbH
 Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Finance |
Protagen AG
 Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Health Technology |
DIREVO Industrial Biotechnology GmbH
DIREVO Industrial Biotechnology GmbH Miscellaneous Commercial ServicesCommercial Services DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany. | Commercial Services |
Cryotherapeutics SA
 Cryotherapeutics SA Medical SpecialtiesHealth Technology Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany. | Health Technology |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Health Technology |
Fasciotens GmbH
Fasciotens GmbH Packaged SoftwareTechnology Services Fasciotens GmbH engages in the development of external medical device that provides solution for the open abdomen or abdominal compartment syndrome. It offers fasciotens abdomen. The company was founded by Gereon Lill and Frank Beyer in 2016 and is headquartered in Essen, Germany. | Technology Services |
Abalos Therapeutics GmbH
Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany. | Health Technology |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Health Technology |
Resolve BioSciences GmbH
Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Health Technology |
| Cryotherapeutics GmbH |
